{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T04:41:42Z","timestamp":1768538502916,"version":"3.49.0"},"reference-count":58,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T00:00:00Z","timestamp":1768435200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Toxins"],"abstract":"<jats:p>Cell-based potency assays (CBPAs) are required for the potency testing and commercial release of botulinum neurotoxin (BoNT)-based drug products. These CBPAs must account for the toxin\u2019s biological activities while meeting regulatory guidelines for precision and accuracy. Here, studies describe the characterization and qualification of the BoSapient CBPA and demonstrate that it is fit for use as a relative potency assay for BoNT\/A-containing samples. The CBPA is operated in a 96-well plate format and relies upon the fluorescence emissions of a reporter that directly responds to BoNT\/A activity. The BoSapient cell line expresses the BoNT\/A-receptors SV2 and complex gangliosides, is responsive only to intact BoNT\/A, and can robustly detect picomolar and sub-picomolar BoNT\/A quantities, making the CBPA appropriate for quantifying BoNT\/A-based drug products. The cell line was passaged 30 times without significant loss of reporter expression or BoNT\/A sensitivity. Manual and semi-automated CBPA methods were developed and qualified according to regulatory guidelines and shown to have low bias (&lt;4% from expected) and high precision (standard deviation &lt; 8) across all test concentrations. Furthermore, the semi-automated method using the CBPA is demonstrated to improve intermediate precision by 39% compared to the manual method, while reducing operator dependency during method execution.<\/jats:p>","DOI":"10.3390\/toxins18010045","type":"journal-article","created":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T11:13:21Z","timestamp":1768475601000},"page":"45","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A Cell-Based Potency Assay for Determining the Relative Potency of Botulinum Neurotoxin A Preparations Using Manual and Semi-Automated Procedures"],"prefix":"10.3390","volume":"18","author":[{"given":"F. Mark","family":"Dunning","sequence":"first","affiliation":[{"name":"BioSentinel Inc., 505 S. Rosa Road, Madison, WI 53719, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Hendrickson","sequence":"additional","affiliation":[{"name":"BioSentinel Inc., 505 S. Rosa Road, Madison, WI 53719, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Serena","family":"Wolfe","sequence":"additional","affiliation":[{"name":"BioSentinel Inc., 505 S. Rosa Road, Madison, WI 53719, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Harding","sequence":"additional","affiliation":[{"name":"BioAssay Sciences, Highland, UT 84003, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theresa","family":"Geurs","sequence":"additional","affiliation":[{"name":"BioSentinel Inc., 505 S. Rosa Road, Madison, WI 53719, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy M.","family":"Piazza","sequence":"additional","affiliation":[{"name":"BioSentinel Inc., 505 S. Rosa Road, Madison, WI 53719, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas A.","family":"Little","sequence":"additional","affiliation":[{"name":"BioAssay Sciences, Highland, UT 84003, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-0311-3438","authenticated-orcid":false,"given":"Ward C.","family":"Tucker","sequence":"additional","affiliation":[{"name":"BioSentinel Inc., 505 S. Rosa Road, Madison, WI 53719, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2026,1,15]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1086\/444507","article-title":"Botulism","volume":"41","author":"Sobel","year":"2005","journal-title":"Clin. Infect. Dis."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1749-6632.1994.tb26614.x","article-title":"Tetanus and botulinum neurotoxins are zinc proteases specific for components of the neuroexocytosis apparatus","volume":"710","author":"Schiavo","year":"1994","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1111\/j.1471-4159.2009.06093.x","article-title":"Cell entry strategy of clostridial neurotoxins","volume":"109","author":"Binz","year":"2009","journal-title":"J. Neurochem."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Salvarani, F.M., and Vieira, E.V. (2024). Clostridial Infections in Cattle: A Comprehensive Review with Emphasis on Current Data Gaps in Brazil. Animals, 14.","DOI":"10.20944\/preprints202408.0408.v1"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1055\/s-2004-830901","article-title":"Botulism: Update and review","volume":"24","author":"Cherington","year":"2004","journal-title":"Semin. Neurol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1177\/10406387241236725","article-title":"Botulism in fish: A review","volume":"36","author":"Uzal","year":"2024","journal-title":"J. Vet. Diagn. Investig."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Gutierrez-Arnal, J., and Marin, C. (2024). The Latent Threat in Wild Birds: Clostridium botulinum. Vet. Sci., 11.","DOI":"10.3390\/vetsci11010036"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Winner, B.M., Bodt, S.M.L., and McNutt, P.M. (2020). Special Delivery: Potential Mechanisms of Botulinum Neurotoxin Uptake and Trafficking within Motor Nerve Terminals. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21228715"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1083\/jcb.200305098","article-title":"Synaptotagmins I and II mediate entry of botulinum neurotoxin B into cells","volume":"162","author":"Dong","year":"2003","journal-title":"J. Cell Biol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1126\/science.1123654","article-title":"SV2 is the protein receptor for botulinum neurotoxin A","volume":"312","author":"Dong","year":"2006","journal-title":"Science"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.toxicon.2008.12.027","article-title":"Receptor and substrate interactions of clostridial neurotoxins","volume":"54","author":"Brunger","year":"2009","journal-title":"Toxicon"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/S0968-0004(02)02177-1","article-title":"Botulinum and tetanus neurotoxins: Structure, function and therapeutic utility","volume":"27","author":"Turton","year":"2002","journal-title":"Trends Biochem. Sci."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1080\/01421590701568262","article-title":"Botulinum toxin treatment of axial and cervical dystonia","volume":"29","author":"Benecke","year":"2007","journal-title":"Disabil. Rehabil."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.ejogrb.2006.12.014","article-title":"Applications of Botulinum toxin in urogynaecology","volume":"133","author":"Sinha","year":"2007","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ajog.2006.03.108","article-title":"Botulinum toxin: From life-threatening disease to novel medical therapy","volume":"196","author":"Mahajan","year":"2007","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1464-410X.2007.06575.x","article-title":"Botulinum toxin A in the overactive bladder: Current status and future directions","volume":"99","author":"Dmochowski","year":"2007","journal-title":"BJU Int."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"225","DOI":"10.2146\/sp\/06001","article-title":"Unlabeled uses of botulinum toxins: A review, part 2","volume":"63","author":"Cheng","year":"2006","journal-title":"Am. J. Health Syst. Pharm."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1007\/s00204-022-03271-9","article-title":"Toxicology and pharmacology of botulinum and tetanus neurotoxins: An update","volume":"96","author":"Pirazzini","year":"2022","journal-title":"Arch. Toxicol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/164_2020_351","article-title":"Novel Native and Engineered Botulinum Neurotoxins","volume":"263","author":"Steward","year":"2021","journal-title":"Handb. Exp. Pharmacol."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Fonfria, E., Elliott, M., Beard, M., Chaddock, J.A., and Krupp, J. (2018). Engineering Botulinum Toxins to Improve and Expand Targeting and SNARE Cleavage Activity. Toxins, 10.","DOI":"10.3390\/toxins10070278"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0300-9084(00)00216-9","article-title":"How botulinum and tetanus neurotoxins block neurotransmitter release","volume":"82","author":"Humeau","year":"2000","journal-title":"Biochimie"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.molmed.2005.06.012","article-title":"New insights into clostridial neurotoxin-SNARE interactions","volume":"11","author":"Breidenbach","year":"2005","journal-title":"Trends Mol. Med."},{"key":"ref_23","first-page":"541","article-title":"Collaborative study of a method for the detection of Clostridium botulinum and its toxins in foods","volume":"60","author":"Kautter","year":"1976","journal-title":"J. Assoc. Anal. Chem."},{"key":"ref_24","unstructured":"(2001). AOAC official method 977.26 (Sec 17.7.01) Clostridium botulinum and its toxins in foods. Official Methods of Analysis, AOAC Official Method."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1093\/jaoac\/61.1.96","article-title":"Microbiological methods: Standardized assay for Clostridium botulinum toxins","volume":"61","author":"Schantz","year":"1978","journal-title":"J. AOAC"},{"key":"ref_26","unstructured":"Simpson, L.L. (1989). Assays for botulinum and tetanus toxins. Botulinum Neurotoxin and Tetanus Toxin, Academic Press."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1093\/jaoac\/84.1.85","article-title":"Comparison of amplified ELISA and mouse bioassay procedures for determination of botulinal toxins A, B, E, and F","volume":"84","author":"Ferreira","year":"2001","journal-title":"J. AOAC Int."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.biologicals.2003.08.001","article-title":"Role for standards in assays of botulinum toxins: International collaborative study of three preparations of botulinum type A toxin","volume":"31","author":"Sesardic","year":"2003","journal-title":"Biologicals"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/0041-0101(96)00070-0","article-title":"Therapeutic botulinum type A toxin: Factors affecting potency","volume":"34","author":"McLellan","year":"1996","journal-title":"Toxicon"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"14701","DOI":"10.1073\/pnas.0404107101","article-title":"Using fluorescent sensors to detect botulinum neurotoxin activity in vitro and in living cells","volume":"101","author":"Dong","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Fonfria, E., Marks, E., Foulkes, L.M., Schofield, R., Higazi, D., Coward, S., and Kippen, A. (2023). Replacement of the Mouse LD50 Assay for Determination of the Potency of AbobotulinumtoxinA with a Cell-Based Method in Both Powder and Liquid Formulations. Toxins, 15.","DOI":"10.3390\/toxins15050314"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Fernandez-Salas, E., Wang, J., Molina, Y., Nelson, J.B., Jacky, B.P., and Aoki, K.R. (2012). Botulinum neurotoxin serotype A specific cell-based potency assay to replace the mouse bioassay. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0049516"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.bbrc.2010.11.128","article-title":"Sensitive and quantitative detection of botulinum neurotoxin in neurons derived from mouse embryonic stem cells","volume":"404","author":"Pellett","year":"2011","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.vascn.2010.01.003","article-title":"Comparison of the primary rat spinal cord cell (RSC) assay and the mouse bioassay for botulinum neurotoxin type A potency determination","volume":"61","author":"Pellett","year":"2010","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"ref_35","first-page":"605","article-title":"A sensitive cell-based assay for testing potency of botulinum neurotoxin type A","volume":"41","author":"Caliskan","year":"2024","journal-title":"ALTEX"},{"key":"ref_36","first-page":"113","article-title":"A cell-based alternative to the mouse potency assay for pharmaceutical type E botulinum antitoxins","volume":"39","author":"Diamant","year":"2022","journal-title":"ALTEX"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.bbrc.2010.12.132","article-title":"Embryonic stem cell-derived neurons are a novel, highly sensitive tissue culture platform for botulinum research","volume":"405","author":"McNutt","year":"2011","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1021\/bi0356698","article-title":"Uptake of botulinum neurotoxin into cultured neurons","volume":"43","author":"Keller","year":"2004","journal-title":"Biochemistry"},{"key":"ref_39","first-page":"297","article-title":"Botulinum neurotoxin dose-dependently inhibits release of neurosecretory vesicle-targeted luciferase from neuronal cells","volume":"32","author":"Genz","year":"2015","journal-title":"ALTEX"},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Pathe-Neuschafer-Rube, A., Neuschafer-Rube, F., Haas, G., Langoth-Fehringer, N., and Puschel, G.P. (2018). Cell-Based Reporter Release Assay to Determine the Potency of Proteolytic Bacterial Neurotoxins. Toxins, 10.","DOI":"10.3390\/toxins10090360"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"273","DOI":"10.2147\/CCID.S156851","article-title":"Botulinum neurotoxin formulations: Overcoming the confusion","volume":"11","author":"Samizadeh","year":"2018","journal-title":"Clin. Cosmet. Investig. Dermatol."},{"key":"ref_42","first-page":"1","article-title":"Two Feet on the Membrane: Uptake of Clostridial Neurotoxins","volume":"406","author":"Rummel","year":"2017","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1023\/B:GLYC.0000046271.64647.fd","article-title":"Glycosphingolipids-sweets for botulinum neurotoxin","volume":"21","author":"Yowler","year":"2004","journal-title":"Glycoconj. J."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1111\/j.1471-4159.2009.06298.x","article-title":"Botulinum neurotoxins C, E and F bind gangliosides via a conserved binding site prior to stimulation-dependent uptake with botulinum neurotoxin F utilising the three isoforms of SV2 as second receptor","volume":"110","author":"Rummel","year":"2009","journal-title":"J. Neurochem."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/0304-4165(80)90382-7","article-title":"Interaction between Clostridium botulinum neurotoxin and gangliosides","volume":"628","author":"Kitamura","year":"1980","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0041-0101(91)90102-W","article-title":"The translocation of botulinum A neurotoxin by chromaffin cells is promoted in low ionic strength solution and is insensitive to trypsin","volume":"29","author":"Marxen","year":"1991","journal-title":"Toxicon"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"32815","DOI":"10.1074\/jbc.M205258200","article-title":"Botulinum neurotoxin A activity is dependent upon the presence of specific gangliosides in neuroblastoma cells expressing synaptotagmin I","volume":"277","author":"Yowler","year":"2002","journal-title":"J. Biol. Chem."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"6998","DOI":"10.1128\/IAI.73.10.6998-7005.2005","article-title":"Characterization of the antibody response to the receptor binding domain of botulinum neurotoxin serotypes A and E","volume":"73","author":"Baldwin","year":"2005","journal-title":"Infect. Immun."},{"key":"ref_49","unstructured":"USP (2015). Design and Development of Biological Assays. 1032, USP-NF."},{"key":"ref_50","first-page":"42","article-title":"Essentials in Bioassay Development","volume":"32","author":"Little","year":"2019","journal-title":"BioPharm Int."},{"key":"ref_51","unstructured":"Little, T.A. (2021). Best Practices for Analytical Method Validation: Study Design, Analysis, and Acceptance Criteria. BioPharm International Biopharmaceutical Analysis eBook, BioPharm International."},{"key":"ref_52","unstructured":"USP (2015). Biological Assay Validation. 1033, USP-NF."},{"key":"ref_53","unstructured":"ICH (2005). Validation of Analytical Procedures:Text and Methodology. Q2(R1). ICH Harmonised Tripartite Guideline, ICH."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.toxicon.2009.03.021","article-title":"Basic and clinical aspects of BOTOX","volume":"54","author":"Brin","year":"2009","journal-title":"Toxicon"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1080\/09638280701568296","article-title":"Pharmacology of therapeutic botulinum toxin preparations","volume":"29","author":"Dressler","year":"2007","journal-title":"Disabil. Rehabil."},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Rasetti-Escargueil, C., and Popoff, M.R. (2022). Recent Developments in Botulinum Neurotoxins Detection. Microorganisms, 10.","DOI":"10.3390\/microorganisms10051001"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/1040841X.2022.2035315","article-title":"Critical analysis in the advancement of cell-based assays for botulinum neurotoxin","volume":"49","author":"Ambrin","year":"2023","journal-title":"Crit. Rev. Microbiol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"472","DOI":"10.3343\/alm.2024.0581","article-title":"Revolutionizing Laboratory Practices: Pioneering Trends in Total Laboratory Automation","volume":"45","author":"Nam","year":"2025","journal-title":"Ann. Lab. Med."}],"container-title":["Toxins"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6651\/18\/1\/45\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T11:42:01Z","timestamp":1768477321000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6651\/18\/1\/45"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,15]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,1]]}},"alternative-id":["toxins18010045"],"URL":"https:\/\/doi.org\/10.3390\/toxins18010045","relation":{},"ISSN":["2072-6651"],"issn-type":[{"value":"2072-6651","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,15]]}}}